Vascular Implant Surveillance and Interventional Outcomes Network (VISION)

  • Overview

    VISION is an observational study that observes post-market reporting and post-market surveillance in patients over the age of 65 who utilize vascular devices such as those used for endovascular abdominal aortic aneurysm repair. VISION matches procedures in the Society for Vascular Surgery Patient Safety Organization (SVS-PSO) registry – more than 400,000 to date – with Medicare claims and New York State Registry data (SPARCS). VISION has two aims from these results: a) to expand VISION by introducing under-65 all-payer populations, and b) validating against trials for a novel, inexpensive path to real-world evidence.

  • Impact for NESTcc

    The use of Real-World Data (RWD) through Registry and Medicare Claims Data will improve the efficiency, validity, and cost of device surveillance.

  • Organizations

    Society for Vascular Surgery Patient Safety Organization, U.S. Food and Drug Administration (FDA), Weill Cornell Medical Center

  • Principal Investigators

    Philip Goodney, MD, MS, and Art Sedrakyan, MD, PhD for the Society for Vascular Surgery Patient Safety Organization (SVS-PSO)

Follow us @NESTccMedTech

NESTcc's Test-Case study protocol on synthetic mid-urethral slings for stress urinary incontinence in women is open for public comment through June 12. More: bit.ly/2RM654T pic.twitter.com/fk4ore1Kmg 1 day ago

NESTcc is requesting public comments on the study protocol of our Test-Case focused on synthetic mid-urethral slings for stress urinary incontinence in women. The comment period is open until June 12. More: bit.ly/2RM654T pic.twitter.com/5owFLFq1Fl 1 week ago

National Evaluation System for health Technology Coordinating Center (NESTcc)
1501 Wilson Blvd., Suite 910, Arlington, VA 22209

© Copyright 2020 | Privacy Policy

An Initiative of:

MDIC logo

Follow MDIC:

Twitter logo
LinkedIn Logo